Q3 2022 Results

Company overview Financial review Financial performance Cardiovascular Immunology 2022 priorities Innovation: Pipeline overview Neuroscience Appendix Innovation: Clinical trials Clinical Trials Update Includes selected ongoing or recently concluded global trials of Novartis development programs/products which are in confirmatory development or marketed (typically Phase 2b or later). For further information on all Novartis clinical trials, please visit: www.novartisclinicaltrials.com Oncology References Abbreviations Other 43 Investor Relations | Q3 2022 Results NOVARTIS | Reimagining Medicine

View entire presentation